Status:
COMPLETED
RSA Study of Furlong Evolution With and Without Collar
Lead Sponsor:
Region Skane
Collaborating Sponsors:
JRI Orthopaedics Ltd
Conditions:
Hip Replacement in Osteoarthritis Patients
Eligibility:
All Genders
40-80 years
Phase:
NA
Brief Summary
The aim of this study is to further investigate the clinical and radiological importance of design changes in cementless hip prosthesis. The investigators have earlier evaluated the classical Furlong ...
Eligibility Criteria
Inclusion
- Primary osteoarthritis of the hip necessitating primary hip replacement
- A femur considered suitable for uncemented fixation of the stem
- Biological age \<75 years old at the inclusion time of the study.
Exclusion
- Rheumatoid arthritis
- Malignant disease
- Severe osteoporosis
- Earlier fracture or operation in the hip to be operated on
- Peroperative fracture
- Ongoing corticosteroid (oral) or immunosuppressive medication
- Personal disorders (dementia, alcohol or drug abuse etc) suspected of making completion of the trial uncertain.
Key Trial Info
Start Date :
October 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2025
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT01894854
Start Date
October 1 2012
End Date
March 1 2025
Last Update
June 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Orthopedics, Skane University Hospital, Lund University
Lund, Skåne County, Sweden, 221 85